564 related articles for article (PubMed ID: 34689373)
1. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
2. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
[TBL] [Abstract][Full Text] [Related]
4. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and comparison of short chain fatty acids composition in gut diseases.
Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
[TBL] [Abstract][Full Text] [Related]
6. Changes in gut microbiota and short-chain fatty acids are involved in the process of canine obesity after neutering.
Yang K; Lin X; Jian S; Wen J; Jian X; He S; Wen C; Liu T; Qi X; Yin Y; Deng B
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37632755
[TBL] [Abstract][Full Text] [Related]
7. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
[TBL] [Abstract][Full Text] [Related]
8. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
[TBL] [Abstract][Full Text] [Related]
9. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease.
Tao P; Ji J; Wang Q; Cui M; Cao M; Xu Y
Front Immunol; 2022; 13():1080456. PubMed ID: 36601125
[TBL] [Abstract][Full Text] [Related]
10. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
11. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
Opeyemi OM; Rogers MB; Firek BA; Janesko-Feldman K; Vagni V; Mullett SJ; Wendell SG; Nelson BP; New LA; Mariño E; Kochanek PM; Bayır H; Clark RSB; Morowitz MJ; Simon DW
J Neurotrauma; 2021 Sep; 38(18):2610-2621. PubMed ID: 33957773
[TBL] [Abstract][Full Text] [Related]
12. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
13. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
[TBL] [Abstract][Full Text] [Related]
14. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
Chai L; Luo Q; Cai K; Wang K; Xu B
BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
[TBL] [Abstract][Full Text] [Related]
16. Young versus aged microbiota transplants to germ-free mice: increased short-chain fatty acids and improved cognitive performance.
Lee J; Venna VR; Durgan DJ; Shi H; Hudobenko J; Putluri N; Petrosino J; McCullough LD; Bryan RM
Gut Microbes; 2020 Nov; 12(1):1-14. PubMed ID: 32897773
[TBL] [Abstract][Full Text] [Related]
17. Fecal short-chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy.
Minamoto Y; Minamoto T; Isaiah A; Sattasathuchana P; Buono A; Rangachari VR; McNeely IH; Lidbury J; Steiner JM; Suchodolski JS
J Vet Intern Med; 2019 Jul; 33(4):1608-1618. PubMed ID: 31099928
[TBL] [Abstract][Full Text] [Related]
18. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
20. Chronotropic and vasoactive properties of the gut bacterial short-chain fatty acids in larval zebrafish.
Sree Kumar H; Wisner AS; Schiefer IT; Alviter Plata A; Zubcevic J
Physiol Genomics; 2024 Jun; 56(6):426-435. PubMed ID: 38557279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
